Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Pcmt1em1/Cya
Common Name:
Pcmt1-KO
Product ID:
S-KO-03571
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Pcmt1-KO
Strain ID
KOCMP-18537-Pcmt1-B6J-VA
Gene Name
Pcmt1
Product ID
S-KO-03571
Gene Alias
PIMT
Background
C57BL/6JCya
NCBI ID
18537
Modification
Conventional knockout
Chromosome
10
Phenotype
MGI:97502
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Pcmt1em1/Cya mice (Catalog S-KO-03571) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000159917
NCBI RefSeq
NM_008786
Target Region
Exon 2~3
Size of Effective Region
~1.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
PCMT1, also known as protein-L-isoaspartate (D-aspartate) O-methyltransferase, is a repair enzyme. It catalyzes the conversion of isomerized aspartic acid (iso-Asp) residues into their normal structure, restoring the configuration and function of proteins [2]. It has been implicated in various pathways related to cancer progression, such as the integrin-FAK-Src pathway [1], and the PI3K/AKT/GSK-3β pathway [2].

Genome-wide Nuclease technology knockout screen identified PCMT1 as a critical driver of anoikis resistance in ovarian cancer. PCMT1 knockdown/knockout experiments showed that it enhanced cell migration, adhesion, and spheroid formation in vitro, and in vivo, overexpression led to increased ascites formation and distant metastasis, while knockout had the opposite effect [1]. In prostate cancer, PCMT1 knockdown/overexpression experiments demonstrated that it promoted cell proliferation, migration, invasion, and inhibited apoptosis, acting through the PI3K/AKT/GSK-3β pathway [2]. In liver cancer, in vitro and in vivo experiments with PCMT1 knockdown showed inhibition of cancer cell proliferation and migration, promotion of apoptosis, and reduced tumor growth rate [3]. In breast cancer, in vitro experiments with PCMT1 knockdown decreased cell migration and invasiveness, and animal studies confirmed that its inhibition slowed tumor growth [4]. Also, silencing PCMT1 enhanced the sensitivity of breast cancer cells to paclitaxel [5]. In cervical cancer, high expression of PCMT1 was associated with decreased overall survival [6]. In bladder cancer, PCMT1 regulated cell migration and invasion through modulating epithelial-mesenchymal transition (EMT)-associated genes, and its high-expression was an independent unfavorable prognostic factor [7].

In conclusion, PCMT1 plays a significant role in cancer-related biological processes. Through gene knockout and knockdown studies in various cancer models, it has been shown to promote cancer cell proliferation, migration, invasion, and inhibit apoptosis, and is related to poor prognosis in multiple cancers. These findings highlight the potential of PCMT1 as a therapeutic target in cancer treatment.

References:

1. Zhang, Jingjing, Li, Yun, Liu, Hua, Xu, Yingjie, Feng, Weiwei. 2022. Genome-wide Nuclease technology library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. In Journal of experimental & clinical cancer research : CR, 41, 24. doi:10.1186/s13046-022-02242-3. https://pubmed.ncbi.nlm.nih.gov/35033172/

2. Zhong, Jiacheng, Yuan, Chao, Liu, Lin, Liu, Guiyong, Liu, Xiuheng. 2023. PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway. In Aging, 15, 11654-11671. doi:10.18632/aging.205152. https://pubmed.ncbi.nlm.nih.gov/37899170/

3. Liu, Jiahao, Liu, Baiying, Li, Yanan, Tan, Hongpei, Rong, Pengfei. 2023. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer. In European journal of medical research, 28, 289. doi:10.1186/s40001-023-01216-1. https://pubmed.ncbi.nlm.nih.gov/37596654/

4. Liu, Yiqi, Li, Haobing, Shen, Xiangyu, Zhong, Jing, Cao, Renxian. 2024. PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis. In American journal of cancer research, 14, 3711-3732. doi:10.62347/TYLL7952. https://pubmed.ncbi.nlm.nih.gov/39267673/

5. Zhang, Ke, Li, Jin-You, Li, Kai. . Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway. In Chemical biology & drug design, 103, e14559. doi:10.1111/cbdd.14559. https://pubmed.ncbi.nlm.nih.gov/38853025/

6. Shan, Liyun, Wang, Xiaoyun, Li, Yanli, Xi, Xiaowei, Yang, Yongbin. . Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer. In Translational cancer research, 11, 2582-2590. doi:10.21037/tcr-21-2700. https://pubmed.ncbi.nlm.nih.gov/36093534/

7. Dong, Liming, Li, Yanpei, Xue, Dongwei, Liu, Yili. 2018. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer. In IUBMB life, 70, 291-299. doi:10.1002/iub.1717. https://pubmed.ncbi.nlm.nih.gov/29517839/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest